NASDAQ · CLOV

Clover Health Investments, Corp.

Closing price · Nov 13, 2026 $4.96

Latest quarter · ended Sep 30, 2026

Sales grew and cash improved

descriptionFiled Nov 6, 2026
Revenue growthSlower
+52.9%
Quarter ended Dec 31, 2024: +7.9% sales vs. a year beforeQuarter ended Mar 31, 2025: +33.3% sales vs. a year beforeQuarter ended Jun 30, 2025: +34.1% sales vs. a year beforeQuarter ended Sep 30, 2025: +50.1% sales vs. a year beforeQuarter ended Dec 31, 2025: +44.7% sales vs. a year beforeQuarter ended Mar 31, 2026: +62.0% sales vs. a year beforeQuarter ended Jun 30, 2026: +55.6% sales vs. a year beforeQuarter ended Sep 30, 2026: +52.9% sales vs. a year before
Dec '24Sep '26
$759M vs. $497M a year ago
Cash from operationsBetter
$70.4M
Quarter ended Dec 31, 2024: −$85.8M cash from operationsQuarter ended Mar 31, 2025: −$16.3M cash from operationsQuarter ended Jun 30, 2025: $5.41M cash from operationsQuarter ended Sep 30, 2025: $12.1M cash from operationsQuarter ended Dec 31, 2025: −$68.2M cash from operationsQuarter ended Mar 31, 2026: $108M cash from operationsQuarter ended Jun 30, 2026: $25.2M cash from operationsQuarter ended Sep 30, 2026: $70.4M cash from operations
Dec '24Sep '26
+482% from $12.1M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −100
  • info
    4 real insider sales in 12 months. $1.06M in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

227 funds report owning CLOV, up from 207

Holdings as of Jun 30, 2026
New49
Added75
Held58
Trimmed45
Sold out29

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovShares withheld for tax · Dec 14 · $300K · 2 peopleShares withheld for tax · Dec 15 · $23.5KShares withheld for tax · Dec 15 · $17.3KPlanned sale (10b5-1) · Dec 18 · $12.8KShares withheld for tax · Jan 1 · $630KShares withheld for tax · Jan 3 · $19.5KStock grant · Jan 6 · 396,825 sh · 5 peopleOption exercise · Jan 7 · 1.66M shShares withheld for tax · Jan 7 · $4.29MPlanned sale (10b5-1) · Jan 7 · $5.32KShares withheld for tax · Jan 15 · $336K · 4 peopleShares withheld for tax · Jan 15 · $32.8KShares withheld for tax · Jan 18 · $93.8KPlanned sale (10b5-1) · Jan 20 · $11.9KShares withheld for tax · Jan 29 · $362KShares withheld for tax · Feb 8 · $183KShares withheld for tax · Feb 14 · $12.3KShares withheld for tax · Mar 14 · $216K · 2 peopleShares withheld for tax · Mar 15 · $12.3KShares withheld for tax · Mar 15 · $8.97KPlanned sale (10b5-1) · Mar 18 · $11.1KStock grant · Apr 1 · 1.57M sh · 4 peopleStock grant · Apr 1 · 382,522 shShares withheld for tax · Apr 1 · $545KShares withheld for tax · Apr 3 · $10.7KShares withheld for tax · Apr 15 · $229K · 4 peopleShares withheld for tax · Apr 15 · $20.7KShares withheld for tax · Apr 15 · $8.48KShares withheld for tax · Apr 18 · $79.1KShares withheld for tax · May 8 · $242KShares withheld for tax · May 16 · $58.8KPlanned sale (10b5-1) · May 28 · $879KPlanned sale (10b5-1) · Jun 11 · $35.8KPlanned sale (10b5-1) · Jun 15 · $29.3KPlanned sale (10b5-1) · Jun 15 · $21.6KPlanned sale (10b5-1) · Jun 16 · $58.8KPlanned sale (10b5-1) · Jun 17 · $11.3KPlanned sale (10b5-1) · Jul 1 · $1.67MPlanned sale (10b5-1) · Jul 6 · $32.8KPlanned sale (10b5-1) · Jul 8 · $11.2KPlanned sale (10b5-1) · Jul 15 · $467K · 3 peoplePlanned sale (10b5-1) · Jul 15 · $49.1KPlanned sale (10b5-1) · Jul 15 · $21.6KPlanned sale (10b5-1) · Jul 17 · $21.9KPlanned sale (10b5-1) · Jul 20 · $233KPlanned sale (10b5-1) · Aug 10 · $408KStock grant · Aug 12 · 108,695 shStock grant · Aug 12 · 54,347 shPlanned sale (10b5-1) · Aug 17 · $78KPlanned sale (10b5-1) · Sep 15 · $1.46M · 2 peoplePlanned sale (10b5-1) · Sep 15 · $32.7KPlanned sale (10b5-1) · Sep 16 · $14.7KPlanned sale (10b5-1) · Sep 17 · $8.76KStock grant · Sep 30 · 24,962 sh · 2 peoplePlanned sale (10b5-1) · Oct 1 · $1.34MPlanned sale (10b5-1) · Oct 5 · $38.7KPlanned sale (10b5-1) · Oct 7 · $9.29KPlanned sale (10b5-1) · Oct 15 · $487K · 3 peoplePlanned sale (10b5-1) · Oct 15 · $68.7KPlanned sale (10b5-1) · Oct 15 · $21.5KPlanned sale (10b5-1) · Oct 19 · $17.9KPlanned sale (10b5-1) · Oct 20 · $89.8KStock grant · Nov 4 · 186,403 shStock grant · Nov 4 · 328,947 shOpen-market sale · Mar 4 · $380KOpen-market sale · May 13 · $345KOpen-market sale · May 18 · $230KOpen-market sale · Sep 14 · $103K
CEOCFOOther officersDirectorsJunJulAugSepOctNovPlanned sale (10b5-1) · Jun 11 · $35.8KPlanned sale (10b5-1) · Jun 15 · $29.3KPlanned sale (10b5-1) · Jun 15 · $21.6KPlanned sale (10b5-1) · Jun 16 · $58.8KPlanned sale (10b5-1) · Jun 17 · $11.3KPlanned sale (10b5-1) · Jul 1 · $1.67MPlanned sale (10b5-1) · Jul 6 · $32.8KPlanned sale (10b5-1) · Jul 8 · $11.2KPlanned sale (10b5-1) · Jul 15 · $467K · 3 peoplePlanned sale (10b5-1) · Jul 15 · $49.1KPlanned sale (10b5-1) · Jul 15 · $21.6KPlanned sale (10b5-1) · Jul 17 · $21.9KPlanned sale (10b5-1) · Jul 20 · $233KPlanned sale (10b5-1) · Aug 10 · $408KStock grant · Aug 12 · 108,695 shStock grant · Aug 12 · 54,347 shPlanned sale (10b5-1) · Aug 17 · $78KPlanned sale (10b5-1) · Sep 15 · $1.46M · 2 peoplePlanned sale (10b5-1) · Sep 15 · $32.7KPlanned sale (10b5-1) · Sep 16 · $14.7KPlanned sale (10b5-1) · Sep 17 · $8.76KStock grant · Sep 30 · 24,962 sh · 2 peoplePlanned sale (10b5-1) · Oct 1 · $1.34MPlanned sale (10b5-1) · Oct 5 · $38.7KPlanned sale (10b5-1) · Oct 7 · $9.29KPlanned sale (10b5-1) · Oct 15 · $487K · 3 peoplePlanned sale (10b5-1) · Oct 15 · $68.7KPlanned sale (10b5-1) · Oct 15 · $21.5KPlanned sale (10b5-1) · Oct 19 · $17.9KPlanned sale (10b5-1) · Oct 20 · $89.8KStock grant · Nov 4 · 186,403 shStock grant · Nov 4 · 328,947 shOpen-market sale · Sep 14 · $103K

Last 6 months. A wider screen shows 12.

Showing 4 real trades. Hidden: 16 stock grants, 31 tax withholdings, 1 option exercise, 37 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Sep 14 Joseph Oldakowski VP of Finance and Controller Open-market sale $103K 20,000 sh at $5.16 Sold 7% of stake
May 18 Carladenise Edwards Director Open-market sale $230K 67,160 sh at $3.42 Sold 19% of stake
May 13 Brady Priest CEO of Clover Care Services Open-market sale $345K 98,039 sh at $3.52 Sold 5% of stake
Mar 4 Brady Priest CEO of Home Care Open-market sale $380K 175,000 sh at $2.17 Sold 8% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CLOV

As of Jun 30, 2026
FundValueChange
California State Teachers Retirement System$462M+387%
BlackRock, Inc.$184M+10%
Vanguard Capital Management LLC$94.5M+6%
Geode Capital Management, LLC$56.8M+8%
State Street Corp$53.3M+6%

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast